People: 3D Systems Corp (DDD.N)

DDD.N on New York Stock Exchange

21.96USD
22 May 2015
Change (% chg)

$-0.26 (-1.17%)
Prev Close
$22.22
Open
$22.23
Day's High
$22.59
Day's Low
$21.82
Volume
391,979
Avg. Vol
506,810
52-wk High
$69.56
52-wk Low
$20.83

Search Stocks

Curran, William 

Mr. William Edward Curran is Independent Director of 3D Systems Corp. Currently retired, Mr. Curran serves as a director of Profound Medical, an early stage company developing a treatment for prostate cancer using ablative ultrasound and guided by magnetic resonance imaging and thermometry. Previously, Mr. Curran served as non-executive Chairman and Director of Resonant Medical, an early-stage privately owned company specializing in three-dimensional ultrasound image-guided adaptive radio therapy products, until May 2010 at which time Resonant was sold to Elekta A.B. He also served until May 2009 as a director of Ventracor, a global medical device company which produced an implantable blood pump, at which time the directors brought in an administrator under Australian law. For more than five years prior to 2004, he held diverse functional and senior management positions with Philips Electronics and Philips Medical Systems. His experience at Philips Medical Systems, a medical device manufacturer, included positions as Chief Operating Officer and Chief Financial Officer, and while at Philips Electronics North America he served as President and Chief Executive Officer as well as Chief Financial Officer. First elected a director in 2008, Mr. Curran brings to the Board wide experience in operations, finance and executive management both in the United States and abroad.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

G. Walter Loewenbaum

--

Abraham Reichental

6,640,680

David Styka

--

Mark Wright

2,386,360

Charles Hull

2,773,360

Kevin McAlea

2,225,080
As Of  30 Dec 2014
Search Stocks